BYBY
Dr.Dr. SAMINATHAN KAYAROHANAMSAMINATHAN KAYAROHANAM
M.PHARM, M.B.A, PhDM.PHARM, M.B.A, PhD
IMMUNOSUPPRESSANTS
11
2
NUM CONTENT SLIDE
1 INTRODUCTION TO IMMUNITY 4,5
2 TYPES OF IMMUNITY 6-11
3 WHAT IS ANTIGENA AND ANTIBODY 12
4 TYPE OF ANTIGENS 13
5 TYPE OF ANTIBODY 14
6 ANTIBODY TARGETS AND FUNCTIONS 15
7 ANTIGEN AND ANTIBODY ACTION/REACTION 16,17
8 NON SPECIFIC DEFENSES 18,19
9 CELLS AND MOLECULES OF IMMUNE RESPONSE 20-22
10 INTRODUCTION TO IMMUNOSUPPRESSANT 23
11 CLASSIFICATION OF IMMUNOSUPPRESSANTS 25
12 ORGAN TRANSPLANT REJECTION 26
13 MECHANISM OF CYCLOSPORINE AND TACROLIMUS 28
14 MECHANISM OF SIROLIMUS AND TACROLIMUS 30
15 MECHANISM OF MYCOPHENOLATE 31
16 ACTION OF IMMUNOSUPPRESSANTS 32
17 SIDE EFFECTS IMMUNOSUPPRESSANTS 33
LEARNING OUTCOME
1. Able to understand the immunity and different types of
immunity.
2. Able to demonstrate the antigen, antibody and
different types of antibody.
3. Able to understand the immunosuppressant and the
diseases treated with immunosuppressant drugs .
4. Able to list the immunosuppressant drugs
classification.
5. Abele to demonstrate the mechanism of
immunosuppressant drugs.
6. Describe the toxic effects of immunosuppressant drugs .
4
1. INTRODUCTION TO IMMUNITY
Immunity is the resistance of an organism to infection or
disease.
Immunity is the state of sufficient biological defences to
avoid infection, disease, or other unwanted biological
invasion.”
In biology, immunity is the state of having sufficient
biological defences to avoid infection, disease, or other
unwanted biological invasion. It is the capability of the
body to resist harmful microbesfrom entering it.
Con…
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
5
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
2. TYPES OF IMMUNITY
Con…
A B
6
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
7
 Innate immunity is non- specific. It is first lines of defence.
They defences include secretion of chemical signals, phagocytic
activity, antimicrobial substance and fever.
Examples
Neutrophils,Eosinophils,Mast cells, Monocytes,
Macrophages, Killer cell, Platelets
 Innate immunity also comes in a protein chemical form, called
innate humoral immunity. If an antigen gets past these barriers,
it is attacked and destroyed by other parts of the immune
system.
Examples
Cough reflex, Enzymes in tears and skin oils, Mucus (which
traps bacteria and small particles),Skin, Stomach acid
 2. A. INNATE IMMUNITY
Con…
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
8
FIRST LINE OF DEFENCE – NON-SPECIFIC BARRIERS
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
9
2.B. TYPE OF ACQUIRED IMMUNITY
Con…
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
10
Con…
2.B. TYPE OF ACQUIRED IMMUNITY
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
11
PRODUCTION OF MONOCLONAL ANTIBODIES BY
THE HYBRIDOMA METHOD
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
12
An antigen may be a foreign substance from the
environment such as chemicals, bacteria, viruses, or
pollen. An antigen may also be formed within the body,
as with bacterial toxins or tissue cells. An antigen is any
substance that causes your immune system to produce 
antibodies against it.
An antibody (Ab), also known as
an immunoglobulin (Ig), is a large Y-shape  protein
 produced by B cells that is used by the immune system
to identify and neutralize foreign objects such as 
bacteria and viruses. The antibody recognizes a unique
part of the foreign target, called anantigen.
3. WHAT IS ANTIGENA AND ANTIBODY?
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
1.Exogenous antigens
Exogenous antigens are antigens that have entered the body from the outside,
for example by inhalation, ingestion, or injection.
2.Endogenous antigens
Endogenous antigens are antigens that have been generated within previously
normal cells as a result of normal cell metabolism, or because of viral or
intracellular bacterial infection.
3.Autoantigens
An autoantigen is usually a normal protein or complex of proteins (and
sometimes DNA or RNA) that is recognized by the immune system of patients
suffering from a specific autoimmune disease.
4.Tumour antigens or neoantigens
Those antigens that are presented by MHC I or MHC II molecules on the
surface of tumor cells. These antigens can sometimes be presented by tumor
cells and never by the normal ones. In this case, they are called
tumor-specific antigens (TSAs) and, in general, result from a tumor-specific
mutation.
4. TYPE OF ANTIGENS
13
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
5. TYPE OF ANTIBODY
14
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
15
6. ANTIBODY TARGETS AND FUNCTIONS
15 Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
7. ANTIGEN AND ANTIBODY ACTION/REACTION
Con…
16
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
7. ANTIGEN AND ANTIBODY ACTION/REACTION
Con…
17
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
8. NON SPECIFIC DEFENSES
Con…
18
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
8. NON SPECIFIC DEFENSES
19
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
9. CELLS AND MOLECULES OF IMMUNE RESPONSE
Con…
20
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
9. CELLS AND MOLECULES OF IMMUNE RESPONSE
Con…
21
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
9. CELLS AND MOLECULES OF IMMUNE RESPONSE
22
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
23
Immunosuppressant drugs are a class of drugs that suppress or reduce
the strength of the body’s immune system. They are also called anti-
rejection drugs. One of the primary uses of immunosuppressant drugs is
to lower the body’s ability to reject a transplanted organ, such as a liver,
heart or kidney.
Almost everyone who receives an organ transplant has to take
immunosuppressant drugs. The body recognizes a transplanted organ as
a foreign mass. This triggers a response by the body’s immune system to
attack it.
By weakening the immune system, immunosuppressant drugs
decrease the body’s reaction to the foreign organ. The drugs allow the
transplanted organ to remain healthy and free from damage
10. INTRODUCTION TO IMMUNOSUPPRESSANT
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
24
Immunosuppressant drugs also are used to treat autoimmune
diseases such as lupus. An autoimmune disorder is a disease
process in which the body attacks its own tissue. Lupus results
from just such a misdirected activity of the body’s own immune
system. By suppressing this reaction, immunosuppressant
drugs can help control the impact of the disease on the body.
OTHER DISEASES TREATED WITH IMMUNOSUPPRESSANT DRUGS INCLUDE:
•Psoriasis
•Rheumatoid arthritis
•Crohn’s disease, a chronic inflammation of the digestive tract
•Multiple sclerosis
•Alopecia areata (patchy hair loss)
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
25
11. CLASSIFICATION OF
IMMUNOSUPPRESSANTS
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
26
1. ABO-incompatible transplants
2 Immunologic mechanisms of rejection
•2.1 Immunization
•2.2 Immune memory
•2.3 Cellular immunity
•2.4 Humoral immunity
o2.4.1 Antibody
o2.4.2 Opsonization
o2.4.3 Complement cascade
3 Medical categories of rejection
•3.1 Hyperacute rejection
•3.2 Acute rejection
•3.3 Chronic rejection
4 Rejection due to non-adherence
12. ORGAN TRANSPLANT REJECTION
Con…
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
27
12.ORGAN TRANSPLANT REJECTION
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
28
13. MECHANISM OF CYCLOSPORINE AND TACROLIMUS
Il-2 = interleukin-2; mTOR = mammalian target of rapamycin;
NFATc = cytosolic nuclear factor of activated T cells Con…
29
Cyclosporine preferentially suppresses cell-mediated immune
reactions
After diffusing into the T cell, Cyclosporine binds to a
cyclophilin (more generally called an immunophilin) to form a
complex that binds to calcineurin.
The latter is responsible for dephosphorylating NFATc
(cytosolic Nuclear Factor of Activated T cells).
The CsA-calcineurin complex cannot perform this reaction;
thus, NFATc cannot enter the nucleus to promote the reactions
that are required for the synthesis of a number of cytokines,
including IL-2.
The end result is a decrease in IL-2 the primary chemical
stimulus for increasing the number of T lymphocytes.
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
30+
14. MECHANISM OF SIROLIMUS AND TACROLIMUS
SIROLIMUS AND TACROLIMUS bind to
the same cytoplasmic FK-binding protein,
but instead of forming a complex with
calcineurin, SRL binds to molecular
target of rapamycin interfering with
Signal.
The latter is a serine-threoninekinase
Binding of SIROLIMUS to molecular
target of rapamycin blocks the
progression of activated T cells from the
G1 to the S phase of the cell cycle and,
consequently, the proliferation of these
cells.
Unlike Cyclosporine and Sirolimus and
Tacrolimus does not owe its effect to
lowering IL-2 production but, rather, to
inhibiting the cellular responses to IL-2.
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
31
Mycophenolate safety and efficacy in
prolonging graft survival.
It has been successfully used in heart,
kidney, and liver transplants.
As an ester, it is rapidly hydrolyzed in the
gastrointestinal tract to mycophenolic
acid (MPA), which is a potent, reversible,
uncompetitive inhibitor of inosine
monophosphate dehydrogenase,
blocking the de novo formation of
guanosine phosphate.
Thus, like 6-MP, it deprives the rapidly
proliferating T and B cells of a key
component of nucleic acids.
15. MECHANISM OF MYCOPHENOLATE
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
32
16.ACTION OF IMMUNOSUPPRESSANTS
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
33
•Nausea, vomiting, diarrhea, or stomach ulcers.
•Rash.
•General feeling of being ill (malaise).
•Liver inflammation.
Rare side effects include:
•Suppression of blood cell production (bone marrow
suppression), which may increase the risk of infection
or serious bleeding. Return to normal blood cell
production may take several weeks after the medicine
is stopped.
•Fever
•Inflammation of the pancreas (pancreatitis)
17. SIDE EFFECTS IMMUNOSUPPRESSANTS
Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D

More Related Content

PPTX
Immunosuppressants
PPTX
Immunosuppressants drug
PDF
Immunosuppressants
PDF
Pharmacology - Immunosupressants
PPTX
Development of tooth
PPT
Marketing Environment Marketing
PPTX
mRNA Vaccine - Creative Biolabs
PPTX
Transplantation immunology
Immunosuppressants
Immunosuppressants drug
Immunosuppressants
Pharmacology - Immunosupressants
Development of tooth
Marketing Environment Marketing
mRNA Vaccine - Creative Biolabs
Transplantation immunology

What's hot (20)

PPT
Aminoglycosides
PPTX
immunostimulants
PPTX
Antileprotic drugs
PPTX
Immunosuppressants.pptx
PPTX
immuno stimulants
PPTX
Quinolones
PPTX
Immunopharmacology
PPT
Medicinal chemistry-beta lactam antibiotics
PPT
7.ANTIVIRAL DRUGS
PPTX
Antiprotozoal agents
PPT
Antifungal drugs
PPTX
Antiviral drugs final
PPTX
Anticancer drugs 1 introduction and classification
PPTX
Aminoglycosides
PPTX
Immunosuppressant drugs
PPTX
Pharmacotherapy of asthma and copd
PPTX
Immunostimulants
PPTX
Antifungal drugs
Aminoglycosides
immunostimulants
Antileprotic drugs
Immunosuppressants.pptx
immuno stimulants
Quinolones
Immunopharmacology
Medicinal chemistry-beta lactam antibiotics
7.ANTIVIRAL DRUGS
Antiprotozoal agents
Antifungal drugs
Antiviral drugs final
Anticancer drugs 1 introduction and classification
Aminoglycosides
Immunosuppressant drugs
Pharmacotherapy of asthma and copd
Immunostimulants
Antifungal drugs
Ad

Viewers also liked (8)

PPTX
Immunosuppressants [autosaved]
PPTX
immunosuppression drugs
PPT
5.ANTIMYCOBACTERIALS
PPT
1. INTRODUCTION OF CHEMOTHERAPY
PPT
4.QUINOLONES AND FOLIC ACID ANTAGONISTS
PPT
12.COMPREHENSIVE OFANTIMICROBIAL AGENTS AND CHEMOTHERAPY ( CLASSIFICATION AND...
PPT
2.ANTIBIOTIC (CELL WALL INHIBITORS)
PPT
3. ANTIBIOTIC (PROTEIN SYNTHESIS INHIBITORS)
Immunosuppressants [autosaved]
immunosuppression drugs
5.ANTIMYCOBACTERIALS
1. INTRODUCTION OF CHEMOTHERAPY
4.QUINOLONES AND FOLIC ACID ANTAGONISTS
12.COMPREHENSIVE OFANTIMICROBIAL AGENTS AND CHEMOTHERAPY ( CLASSIFICATION AND...
2.ANTIBIOTIC (CELL WALL INHIBITORS)
3. ANTIBIOTIC (PROTEIN SYNTHESIS INHIBITORS)
Ad

Similar to 11.IMMUNOSUPPRESSANTS (20)

PPTX
Immunomodulators by Kinjan Mehta
PPTX
Immunomodulators
PPTX
mat chemotherapy .pptxghjjbhgggvbhhhhhjjj
PPTX
Antibiotics and other chemotherapeutic agents -Antimicrobial spectrum and mod...
PDF
CHEMOTHERAPY_RDP_GENERAL PRINCIPLES OF CHEMOTHERAPY.pdf
PPTX
Immunosurveillance
PPTX
DLHB2j6YnYTdcGMN13.pptxvvcctfgtggfyggggfyt
DOCX
Monoclonal antibody
DOCX
Monoclonal antibody
PPT
Immunotherapy presentation from clinical immunology
PPT
Immunopharmacology
PPTX
Antibiotic sensitivity and resistance .pptx seminar 2
PPTX
Monoclinal antibodies and gene therapt 1
PPTX
Immunostimulants & immunosuppressants
PPTX
Anti Radiation Antidote: Inhibition and neutralization of Radiation Toxicity...
PPTX
Antibiotics resistance
PPTX
IMMUNOMODULATOR (Aarti pal).pptx Immune system, Types of immunity
PPTX
Immunosuppresant.pptx
PPTX
IMMUNOPHARMACOLOGY
DOCX
Immunotherapeutics
Immunomodulators by Kinjan Mehta
Immunomodulators
mat chemotherapy .pptxghjjbhgggvbhhhhhjjj
Antibiotics and other chemotherapeutic agents -Antimicrobial spectrum and mod...
CHEMOTHERAPY_RDP_GENERAL PRINCIPLES OF CHEMOTHERAPY.pdf
Immunosurveillance
DLHB2j6YnYTdcGMN13.pptxvvcctfgtggfyggggfyt
Monoclonal antibody
Monoclonal antibody
Immunotherapy presentation from clinical immunology
Immunopharmacology
Antibiotic sensitivity and resistance .pptx seminar 2
Monoclinal antibodies and gene therapt 1
Immunostimulants & immunosuppressants
Anti Radiation Antidote: Inhibition and neutralization of Radiation Toxicity...
Antibiotics resistance
IMMUNOMODULATOR (Aarti pal).pptx Immune system, Types of immunity
Immunosuppresant.pptx
IMMUNOPHARMACOLOGY
Immunotherapeutics

Recently uploaded (20)

PPT
intrduction to nephrologDDDDDDDDDy lec1.ppt
PDF
FMCG-October-2021........................
PPTX
gut microbiomes AND Type 2 diabetes.pptx
PPT
fiscal planning in nursing and administration
PPTX
Communicating with the FDA During an Inspection -August 26, 2025 - GMP.pptx
PPTX
Biostatistics Lecture Notes_Dadason.pptx
PPTX
SUMMARY OF EAR, NOSE AND THROAT DISORDERS INCLUDING DEFINITION, CAUSES, CLINI...
PPTX
Bacteriology and purification of water supply
PPTX
Critical Issues in Periodontal Research- An overview
PPTX
Geriatrics_(0).pptxxvvbbbbbbbnnnnnnnnnnk
PPTX
CASE PRESENTATION CLUB FOOT management.pptx
PDF
NCCN CANCER TESTICULAR 2024 ...............................
PPTX
INTESTINAL OBSTRUCTION - IDOWU PHILIP O..pptx
PPTX
ANTI BIOTICS. SULPHONAMIDES,QUINOLONES.pptx
PPTX
Nutrition needs in a Surgical Patient.pptx
PDF
Diabetes mellitus - AMBOSS.pdf
PDF
Cranial nerve palsies (I-XII) - AMBOSS.pdf
PPTX
etomidate and ketamine action mechanism.pptx
PPTX
presentation on causes and treatment of glomerular disorders
PPTX
PLANNING in nursing administration study
intrduction to nephrologDDDDDDDDDy lec1.ppt
FMCG-October-2021........................
gut microbiomes AND Type 2 diabetes.pptx
fiscal planning in nursing and administration
Communicating with the FDA During an Inspection -August 26, 2025 - GMP.pptx
Biostatistics Lecture Notes_Dadason.pptx
SUMMARY OF EAR, NOSE AND THROAT DISORDERS INCLUDING DEFINITION, CAUSES, CLINI...
Bacteriology and purification of water supply
Critical Issues in Periodontal Research- An overview
Geriatrics_(0).pptxxvvbbbbbbbnnnnnnnnnnk
CASE PRESENTATION CLUB FOOT management.pptx
NCCN CANCER TESTICULAR 2024 ...............................
INTESTINAL OBSTRUCTION - IDOWU PHILIP O..pptx
ANTI BIOTICS. SULPHONAMIDES,QUINOLONES.pptx
Nutrition needs in a Surgical Patient.pptx
Diabetes mellitus - AMBOSS.pdf
Cranial nerve palsies (I-XII) - AMBOSS.pdf
etomidate and ketamine action mechanism.pptx
presentation on causes and treatment of glomerular disorders
PLANNING in nursing administration study

11.IMMUNOSUPPRESSANTS

  • 1. BYBY Dr.Dr. SAMINATHAN KAYAROHANAMSAMINATHAN KAYAROHANAM M.PHARM, M.B.A, PhDM.PHARM, M.B.A, PhD IMMUNOSUPPRESSANTS 11
  • 2. 2 NUM CONTENT SLIDE 1 INTRODUCTION TO IMMUNITY 4,5 2 TYPES OF IMMUNITY 6-11 3 WHAT IS ANTIGENA AND ANTIBODY 12 4 TYPE OF ANTIGENS 13 5 TYPE OF ANTIBODY 14 6 ANTIBODY TARGETS AND FUNCTIONS 15 7 ANTIGEN AND ANTIBODY ACTION/REACTION 16,17 8 NON SPECIFIC DEFENSES 18,19 9 CELLS AND MOLECULES OF IMMUNE RESPONSE 20-22 10 INTRODUCTION TO IMMUNOSUPPRESSANT 23 11 CLASSIFICATION OF IMMUNOSUPPRESSANTS 25 12 ORGAN TRANSPLANT REJECTION 26 13 MECHANISM OF CYCLOSPORINE AND TACROLIMUS 28 14 MECHANISM OF SIROLIMUS AND TACROLIMUS 30 15 MECHANISM OF MYCOPHENOLATE 31 16 ACTION OF IMMUNOSUPPRESSANTS 32 17 SIDE EFFECTS IMMUNOSUPPRESSANTS 33
  • 3. LEARNING OUTCOME 1. Able to understand the immunity and different types of immunity. 2. Able to demonstrate the antigen, antibody and different types of antibody. 3. Able to understand the immunosuppressant and the diseases treated with immunosuppressant drugs . 4. Able to list the immunosuppressant drugs classification. 5. Abele to demonstrate the mechanism of immunosuppressant drugs. 6. Describe the toxic effects of immunosuppressant drugs .
  • 4. 4 1. INTRODUCTION TO IMMUNITY Immunity is the resistance of an organism to infection or disease. Immunity is the state of sufficient biological defences to avoid infection, disease, or other unwanted biological invasion.” In biology, immunity is the state of having sufficient biological defences to avoid infection, disease, or other unwanted biological invasion. It is the capability of the body to resist harmful microbesfrom entering it. Con… Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
  • 6. 2. TYPES OF IMMUNITY Con… A B 6 Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
  • 7. 7  Innate immunity is non- specific. It is first lines of defence. They defences include secretion of chemical signals, phagocytic activity, antimicrobial substance and fever. Examples Neutrophils,Eosinophils,Mast cells, Monocytes, Macrophages, Killer cell, Platelets  Innate immunity also comes in a protein chemical form, called innate humoral immunity. If an antigen gets past these barriers, it is attacked and destroyed by other parts of the immune system. Examples Cough reflex, Enzymes in tears and skin oils, Mucus (which traps bacteria and small particles),Skin, Stomach acid  2. A. INNATE IMMUNITY Con… Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
  • 8. 8 FIRST LINE OF DEFENCE – NON-SPECIFIC BARRIERS Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
  • 9. 9 2.B. TYPE OF ACQUIRED IMMUNITY Con… Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
  • 10. 10 Con… 2.B. TYPE OF ACQUIRED IMMUNITY Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
  • 11. 11 PRODUCTION OF MONOCLONAL ANTIBODIES BY THE HYBRIDOMA METHOD Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
  • 12. 12 An antigen may be a foreign substance from the environment such as chemicals, bacteria, viruses, or pollen. An antigen may also be formed within the body, as with bacterial toxins or tissue cells. An antigen is any substance that causes your immune system to produce  antibodies against it. An antibody (Ab), also known as an immunoglobulin (Ig), is a large Y-shape  protein  produced by B cells that is used by the immune system to identify and neutralize foreign objects such as  bacteria and viruses. The antibody recognizes a unique part of the foreign target, called anantigen. 3. WHAT IS ANTIGENA AND ANTIBODY? Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
  • 13. 1.Exogenous antigens Exogenous antigens are antigens that have entered the body from the outside, for example by inhalation, ingestion, or injection. 2.Endogenous antigens Endogenous antigens are antigens that have been generated within previously normal cells as a result of normal cell metabolism, or because of viral or intracellular bacterial infection. 3.Autoantigens An autoantigen is usually a normal protein or complex of proteins (and sometimes DNA or RNA) that is recognized by the immune system of patients suffering from a specific autoimmune disease. 4.Tumour antigens or neoantigens Those antigens that are presented by MHC I or MHC II molecules on the surface of tumor cells. These antigens can sometimes be presented by tumor cells and never by the normal ones. In this case, they are called tumor-specific antigens (TSAs) and, in general, result from a tumor-specific mutation. 4. TYPE OF ANTIGENS 13 Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
  • 14. 5. TYPE OF ANTIBODY 14 Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
  • 15. 15 6. ANTIBODY TARGETS AND FUNCTIONS 15 Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
  • 16. 7. ANTIGEN AND ANTIBODY ACTION/REACTION Con… 16 Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
  • 17. 7. ANTIGEN AND ANTIBODY ACTION/REACTION Con… 17 Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
  • 18. 8. NON SPECIFIC DEFENSES Con… 18 Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
  • 19. 8. NON SPECIFIC DEFENSES 19 Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
  • 20. 9. CELLS AND MOLECULES OF IMMUNE RESPONSE Con… 20 Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
  • 21. 9. CELLS AND MOLECULES OF IMMUNE RESPONSE Con… 21 Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
  • 22. 9. CELLS AND MOLECULES OF IMMUNE RESPONSE 22 Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
  • 23. 23 Immunosuppressant drugs are a class of drugs that suppress or reduce the strength of the body’s immune system. They are also called anti- rejection drugs. One of the primary uses of immunosuppressant drugs is to lower the body’s ability to reject a transplanted organ, such as a liver, heart or kidney. Almost everyone who receives an organ transplant has to take immunosuppressant drugs. The body recognizes a transplanted organ as a foreign mass. This triggers a response by the body’s immune system to attack it. By weakening the immune system, immunosuppressant drugs decrease the body’s reaction to the foreign organ. The drugs allow the transplanted organ to remain healthy and free from damage 10. INTRODUCTION TO IMMUNOSUPPRESSANT Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
  • 24. 24 Immunosuppressant drugs also are used to treat autoimmune diseases such as lupus. An autoimmune disorder is a disease process in which the body attacks its own tissue. Lupus results from just such a misdirected activity of the body’s own immune system. By suppressing this reaction, immunosuppressant drugs can help control the impact of the disease on the body. OTHER DISEASES TREATED WITH IMMUNOSUPPRESSANT DRUGS INCLUDE: •Psoriasis •Rheumatoid arthritis •Crohn’s disease, a chronic inflammation of the digestive tract •Multiple sclerosis •Alopecia areata (patchy hair loss) Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
  • 26. 26 1. ABO-incompatible transplants 2 Immunologic mechanisms of rejection •2.1 Immunization •2.2 Immune memory •2.3 Cellular immunity •2.4 Humoral immunity o2.4.1 Antibody o2.4.2 Opsonization o2.4.3 Complement cascade 3 Medical categories of rejection •3.1 Hyperacute rejection •3.2 Acute rejection •3.3 Chronic rejection 4 Rejection due to non-adherence 12. ORGAN TRANSPLANT REJECTION Con… Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
  • 28. 28 13. MECHANISM OF CYCLOSPORINE AND TACROLIMUS Il-2 = interleukin-2; mTOR = mammalian target of rapamycin; NFATc = cytosolic nuclear factor of activated T cells Con…
  • 29. 29 Cyclosporine preferentially suppresses cell-mediated immune reactions After diffusing into the T cell, Cyclosporine binds to a cyclophilin (more generally called an immunophilin) to form a complex that binds to calcineurin. The latter is responsible for dephosphorylating NFATc (cytosolic Nuclear Factor of Activated T cells). The CsA-calcineurin complex cannot perform this reaction; thus, NFATc cannot enter the nucleus to promote the reactions that are required for the synthesis of a number of cytokines, including IL-2. The end result is a decrease in IL-2 the primary chemical stimulus for increasing the number of T lymphocytes. Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
  • 30. 30+ 14. MECHANISM OF SIROLIMUS AND TACROLIMUS SIROLIMUS AND TACROLIMUS bind to the same cytoplasmic FK-binding protein, but instead of forming a complex with calcineurin, SRL binds to molecular target of rapamycin interfering with Signal. The latter is a serine-threoninekinase Binding of SIROLIMUS to molecular target of rapamycin blocks the progression of activated T cells from the G1 to the S phase of the cell cycle and, consequently, the proliferation of these cells. Unlike Cyclosporine and Sirolimus and Tacrolimus does not owe its effect to lowering IL-2 production but, rather, to inhibiting the cellular responses to IL-2. Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
  • 31. 31 Mycophenolate safety and efficacy in prolonging graft survival. It has been successfully used in heart, kidney, and liver transplants. As an ester, it is rapidly hydrolyzed in the gastrointestinal tract to mycophenolic acid (MPA), which is a potent, reversible, uncompetitive inhibitor of inosine monophosphate dehydrogenase, blocking the de novo formation of guanosine phosphate. Thus, like 6-MP, it deprives the rapidly proliferating T and B cells of a key component of nucleic acids. 15. MECHANISM OF MYCOPHENOLATE Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D
  • 33. 33 •Nausea, vomiting, diarrhea, or stomach ulcers. •Rash. •General feeling of being ill (malaise). •Liver inflammation. Rare side effects include: •Suppression of blood cell production (bone marrow suppression), which may increase the risk of infection or serious bleeding. Return to normal blood cell production may take several weeks after the medicine is stopped. •Fever •Inflammation of the pancreas (pancreatitis) 17. SIDE EFFECTS IMMUNOSUPPRESSANTS Dr.K.Saminathan.M.Pharm, M.B.A, Ph.D